| Literature DB >> 29300976 |
Dipak Kotecha1, Günter Breithardt2,3, A John Camm4, Gregory Y H Lip1, Ulrich Schotten3,5, Anders Ahlsson6, David Arnar7, Dan Atar8, Angelo Auricchio9, Jeroen Bax10, Stefano Benussi11, Carina Blomstrom-Lundqvist12, Martin Borggrefe13, Giuseppe Boriani14, Axel Brandes15, Hugh Calkins16, Barbara Casadei17, Manuel Castellá18, Winnie Chua1, Harry Crijns19, Dobromir Dobrev20, Larissa Fabritz1,21, Martin Feuring22, Ben Freedman23, Andrea Gerth3,24, Andreas Goette3,25, Eduard Guasch18, Doreen Haase3, Stephane Hatem26, Karl Georg Haeusler3,27, Hein Heidbuchel28, Jeroen Hendriks29, Craig Hunter22, Stefan Kääb30, Stefanie Kespohl31, Ulf Landmesser3,32, Deirdre A Lane1, Thorsten Lewalter3,33, Lluís Mont18, Michael Nabauer3,24, Jens C Nielsen34, Michael Oeff3,35, Jonas Oldgren12, Ali Oto36, Laurent Pison37, Tatjana Potpara38, Ursula Ravens3,39, Isabelle Richard-Lordereau40, Michiel Rienstra41, Irina Savelieva4, Renate Schnabel42, Moritz F Sinner30, Philipp Sommer43, Sakis Themistoclakis44, Isabelle C Van Gelder41, Panagiotis E Vardas45, Atul Verma46, Reza Wakili24, Evelyn Weber31, David Werring47, Stephan Willems42, André Ziegler48, Gerhard Hindricks43, Paulus Kirchhof1,2,3.
Abstract
There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The population with AF is expected to expand considerably and yet, apart from anticoagulation, therapies used in AF have not been shown to consistently impact on mortality or reduce adverse cardiovascular events. New approaches to AF management, including the use of novel technologies and structured, integrated care, have the potential to enhance clinical phenotyping or result in better treatment selection and stratified therapy. Here, we report the outcomes of the 6th Consensus Conference of the Atrial Fibrillation Network (AFNET) and the European Heart Rhythm Association (EHRA), held at the European Society of Cardiology Heart House in Sophia Antipolis, France, 17-19 January 2017. Sixty-two global specialists in AF and 13 industry partners met to develop innovative solutions based on new approaches to screening and diagnosis, enhancing integration of AF care, developing clinical pathways for treating complex patients, improving stroke prevention strategies, and better patient selection for heart rate and rhythm control. Ultimately, these approaches can lead to better outcomes for patients with AF.Entities:
Mesh：
Year: 2018 PMID： 29300976 DOI： 10.1093/europace/eux318
Source DB: PubMed Journal: Europace ISSN： 1099-5129 Impact factor: 5.214